Innate and adaptive determinants of host susceptibility to medically important fungi

Current Opinion in Microbiology

Volumn 6, Issue 4, 2003, Pages 344-350

  Huffnagle, Gary B ^a   Deepe Jr , George S ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FUNGUS ANTIBODY; VIRULENCE FACTOR;

ADAPTATION; B LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; FUNGUS; HOST SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; REVIEW; TH1 CELL; TH2 CELL;

FUNGI;

EID: 0042696284     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(03)00089-4     Document Type: Review

References (73)

1. Herring AC, Huffnagle GB: Innate immunity to fungi. In Immunology of Infectious Diseases. Edited by Kaufmann SHE, Sher A, Ahmed R: ASM Press; 2001.
2. Davis MM: T cell receptor gene diversity and selection. Annu Rev Biochem 1990, 59:475-496.
3. Long KH, Gomez FJ, Morris RE, Newman SL: Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol 2003, 170:487-494.
4. Syme RM, Spurrell JC, Amankwah EK, Green FH, Mody CH: Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun 2002, 70:5972-5981.
5. Gildea LA, Morris RE, Newman SL: Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol 2001, 166:1049-1056.
6. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G et al: Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002, 420:182-186. This paper investigates the in vivo role of Ptx3. The Ptx3 knockout mice have defective recognition of Aspergillus fumigatus conidia by alveolar macrophages and dendritic cells and develop type 2 immune responses.
7. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM: Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002, 277:39320-39326.
8. Sieling PA, Modlin RL: Toll-like receptors: mammalian 'taste receptors' for a smorgasbord of microbial invaders. Curr Opin Microbiol 2002, 5:70-75.
9. Liu T, Matsuguchi T, Tsuboi N, Yajima T, Yoshikai Y: Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 2002, 70:6638-6645.
10. Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB: Differential roles of CC chemokine ligand-2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 2002, 168:4659-4666. This article demonstrates that the chemokine receptor CCR2 is required for mature dendritic cell migration into the lymph nodes, presumably because of a blockade in migration from the blood, resulting in a T1 to T2 switch in the pulmonary immune response. The ligand for this activity is not MCP-1.
11. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB: CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 2000, 164:2021-2027.
12. Bauman SK, Huffnagle GB, Murphy JW: Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 2003, 71:68-74.
13. Bozza S, Gaziano R, Spreca A, Bacci A, Montagnoli C, di Francesco P, Romani L: Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002, 168:1362-1371. Results by Bozza et al. and d'Ostiani et al. [13,14] demonstrate that dendritic cells have a functional plasticity and can distinguish between different forms of a fungal species and then differentiate into I-12 or IL-4/ IL-10 producing cells that support disparate T-cell responses.
14. d'Ostiani CF, Del Sero G, Bacci A, Montagnoli C, Spreca A, Mencacci A, Ricciardi-Castagnoli P, Romani L: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000, 191:1661-1674.
15. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
16. Saeki H, Moore AM, Brown MJ, Hwang ST: Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999, 162:2472-2475.
17. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB: Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 2002, 70:2959-2964.
18. Subauste CS, Wessendarp M: Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gamma. J Immunol 2000, 165:1498-1505.
19. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, Yazdanbakhsh M, Kapsenberg ML: Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J Immunol 2002, 168:1704-1709.
20. McGuirk P, Mills KH: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002, 23:450-455.
21. Hori S, Carvalho TL, Demengeot J: CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002, 32:1282-1291. See annotation for Montagnoli et al. [22].
22. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L: B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002, 169:6298-6308. The results by Hori et al. and Montagnoli et al. [21,22] demonstrate that T regulatory cells are generated during fungal infection. Although these authors are the first to classify them as CD4+CD25+ and the studies are well-done, it should be noted that there is a body literature from the late 1980s describing 'suppressor T cells' in Cryptococcus neoformans and Candida albicans infections, notably from Juneann Murphy's laboratory. In light of the latest developments in T cell regulation, it is worthwhile for readers to review these previous data under the current understanding of T cell biology.
23. Bacci A, Montagnoli C, Perruccio K, Bozza S, Gaziano R, Pitzurra L, Velardi A, d'Ostiani CF, Cutler JE, Romani L: Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002, 168:2904-2913.
24. Bozza S, Gaziano R, Lipford GB, Montagnoli C, Bacci A, Di Francesco P, Kurup VP, Wagner H, Romani L: Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002, 4:1281-1290.
25. Faveeuw C, Fougeray S, Angeli V, Fontaine J, Chinetti G, Gosset P, Delerive P, Maliszewski C, Capron M, Staels B et al.: Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett 2000, 486:261-266.
26. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML: Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001, 97:3466-3469.
27. Nencioni A, Grunebach F, Zobywlaski A, Denzlinger C, Brugger W, Brossart P: Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J Immunol 2002, 169:1228-1235.
28. Nencioni A, Lauber K, Grunebach F, Brugger W, Denzlinger C, Wesselborg S, Brossart P: Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp Hematol 2002, 30:1020-1028.
29. Aliberti J, Hieny S, Reise Sousa C, Serhan CN, Sher A: Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002, 3:76-82.
30. Noverr MC, Cox GM, Perfect JR, Huffnagle GB: Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 2003, 71:1538-1547.
31. 2 can modulate fungal biology.
32. Noverr MC, Toews GB, Huffnagle GB: Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 2002, 70:400-402. See annotation for Angeli et al. [34].
33. Noverr MC, Erb-Downward JR, Huffnagle GB: Production of eicosanoids and other oxylipins by eukaryotic microbes. Clin Micro Rev 2003, in press.
34. 2 can block the maturation of dendritic cells (DCs) as they traffic from the skin to the lymph nodes during Schistosome infection, and that DCs do not traffic properly from the skin during schistosome infection. The follow-up to this study and other fungal pathogenesis studies is that knockout organisms will be needed to definitively prove the link; however to date, the correlative data are extremely strong. Noverr et al. [33] review the current state of understanding of oxylipin synthesis by eukaryotic microbes.
35. Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P: Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987, 55:749-752.
36. Sanford JE, Lupan DM, Schlagetter AM, Kozel TR: Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun 1990, 58:1919-1923.
37. Mukherjee J, Scharff MD, Casadevall A: Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 1992, 60:4354-4541.
38. Han Y, Cutler JE: Antibody response that protects against disseminated candidiasis. Infect Immun 1995, 63:2714-2719.
39. Matthews R, Burnie J: Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr Opin Investig Drugs 2001, 2:472-476.
40. st General Meeting of the American Society for Microbiology, 2001, May 20-24, Orlando, Florida.
41. Würthrich M, Klein BS: Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J Infect Dis 2000, 181:1720-1728.
42. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, Niang R, Casadevall A: Serologic evidence for Cryptococcus infection in early childhood. Pediatrics 2001, 107:E66.
43. Wagner RD, Vazquez-Torres A, Jones-Carson J, Warner T, Balish E: B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J Infect Dis 1996, 174:589-597.
44. Han Y, Morrison RP, Cutler JE: A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun 1998, 66:5771-5776.
45. De Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A: Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997, 65:3399-3405.
46. Han Y, Kozel TR, Zhang MX, MacGill RS, Carroll MC, Cutler JE: Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol 2001, 167:1550-1557.
47. Han Y, Cutler JE: Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis 1997, 175:1169-1175.
48. Bromuro C, Torosantucci A, Chiani P, Conti S, Polonelli L, Cassone A: Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect Immun 2002, 70:5462-5470.
49. Taborda CP, Casadevall A: CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 2002, 16:791-802. This manuscript demonstrates that one mechanism by which antibody promotes anti-cryptococcal immunity is by changing the structure of the capsular polysaccharide and thus allowing binding to integrins independent of antibody.
50. + cells in acute, systemic murine candidosis. J Leukoc Biol 1992, 51:305-306.
51. + T cells. J Exp Med 1991, 173:793-800.
52. Allendörfer R, Bunner GD, Deepe GS Jr: Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol 1999, 162:7389-7396.
53. Würthrich M, Filutowicz HI, Warner T, Klein B: Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 2002, 169:6969-6976. This manuscript details the cellular and molecular requirements for vaccine-induced immunity.
54. Cox RA, Magee DM: Protective immunity in coccidioidomycosis. Res Immunol 1998, 149:417-428.
55. Calich VLG, Vaz CAC, Burger E: Immunity to Paracoccidioides brasilensis infection. Res Immunol 1998, 149:407-416.
56. Mencacci A, Del Sero G, Cenci E, d'Ostiani EF, Bacci A, Montagnoli C, Kopf M, Romani L: Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 1998, 187:307-317.
57. + T cells. Annu Rev Immunol 1994, 12:635-674.
58. + myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 2002, 169:3180-3190. This paper demonstrates how neutrophils modulate cellular immunity.
59. Piccinni M-P, Vultaggio A, Scaletti C, Livi C, Gomez MJ, Giudizi MG, Biagiotti R, Cassone A, Romagnani S, Maggi E: Type 1 helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis. J Infect Dis 2002, 186:87-93.
60. Fidel PL Jr, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD: Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997, 176:728-739.
61. + T cell function in anti-cryptococcal immunity.
62. Wuthrich M, Filutowicz HI, Warner T, Deepe GS Jr, Klein BS: Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T Cells: Implications for vaccine development in immune-deficient hosts. J Exp Med 2003, 197:1405-1416.
63. Feldmesser M, Casadevall A: Effect of serum IgG1 against murine pulmonary infection with Cryptococcus neoformans. J Immunol 1997, 158:790-798.
64. Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A: Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun 2001, 69:6445-6455.
65. Yuan R, Casadevall A, Oh J, Scharff MD: T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci USA 1997, 94:2483-2488.
66. Menacacci A, Spaccapelo R, Del Sero G, Enssle KH, Romani L, Bistoni F, Cassone A: A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect Immun 1994, 62:5353-5360.
67. Pietrella D, Mazzolla R, Lupo P, Pitzurra L, Gomez MJ, Cherniak R, Vecchiarelli A: Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice. Infect Immun 2002, 70:6621-6627.
68. Gomez MJ, Maras B, Barca R, LaValle R, Barra D, Cassone A: Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans. Infect Immun 2000, 68:2577-2584.
69. Levitz SM, Nong S, Mansour MK, Huang C, Specht CA: Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T-cell responses to Cryptococcus neoformans. Proc Natl Acad Sci USA 2001, 98:10422-10427.
70. Huang C, Nong S, Mansour MK, Specht CA, Levitz SM: Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses. Infect Immun 2002, 70:5485-5493.
71. Biondo C, Beninati C, Delfino D, Oggioni M, Mancuso G, Midiri A, Bombaci M, Tomaselli G, Teti G: Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infect Immun 2002, 70:2383-2391. This manuscript identifies a deacetylase from Cryptococcus neoformans and demonstrates that it is protective in a murine model of cryptococcal infection.
72. Deepe GS Jr, Gibbons RS: Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect Immun 2002, 70:3759-3767.
73. + cells. J Immunol 2002, 169:5818-5826. This paper demonstrate the organization of the T cell response to a protective antigen from Histoplasma capsulatum.